Workflow
奥精医疗: 华泰联合证券有限责任公司关于奥精医疗科技股份有限公司使用部分募集资金对全资子公司增资以实施募投项目的核查意见

Group 1 - The company plans to use part of the raised funds to increase capital in its wholly-owned subsidiary, Beijing Aojing Medical Equipment Co., Ltd., for the implementation of fundraising projects [1][2] - The total amount of funds raised is approximately RMB 547.67 million, with a net amount of RMB 500.82 million after deducting issuance costs [1][2] - The capital increase will amount to RMB 9.77 million, raising the registered capital of Beijing Aojing Medical Equipment from RMB 39.00 million to RMB 48.77 million, maintaining 100% ownership [2][3] Group 2 - The fundraising projects include the development of guided bone regeneration membranes, artificial bone powder, and mineralized collagen artificial bone repair materials targeted at the U.S. market [2] - The company has established a dedicated account for the raised funds and will implement strict regulatory measures to ensure the safety of the funds [5][6] - The board of directors and the supervisory board have approved the capital increase, which does not require shareholder meeting approval, and complies with relevant regulations [6]